Inflammation and Cancer

Endocr Metab Immune Disord Drug Targets. 2021;21(2):193-194. doi: 10.2174/187153032102210105105653.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / immunology
  • Biomarkers, Tumor / metabolism
  • Gastrointestinal Microbiome / physiology
  • Humans
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / metabolism
  • Inflammation Mediators / antagonists & inhibitors*
  • Inflammation Mediators / immunology
  • Inflammation Mediators / metabolism*
  • Nanotechnology / methods
  • Neoplasms / immunology
  • Neoplasms / metabolism*
  • Neoplasms / therapy*
  • Prebiotics / administration & dosage

Substances

  • Biomarkers, Tumor
  • Inflammation Mediators
  • Prebiotics